High on treatment platelet reactivity as a risk factor for adverse left ventricular remodelling after STEMI

 

Insight on: Park et al. Thromb Haemost 2017; 117: 911-922.

• References

• 1 Cattaneo M. High on-treatment platelet reactivity--definition and measurement. Thromb Haemost 2013; 109: 792-798.
• 2 Westman PC, Lipinski MJ, Luger D. et al. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol 2016; 67: 2050-2060.
• 3 Park Y, Tantry US, Koh J-S. et al. Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial. Thromb Haemost 2017; 117: 911-922.
• 4 Cattaneo M. P2Y12 receptors: structure and function. J Thromb Haemost 2015; 13 (Suppl. 01) S10-16.